Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FBLG
FBLG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FBLG News
FibroBiologics Secures Canadian Patent for Cachexia Treatment
Feb 05 2026
Newsfilter
Align Technology Reports Strong Q4 Earnings Beat
Feb 05 2026
Benzinga
FibroBiologics CEO Pete O'Heeron to Present at DealFlow Discovery Conference on January 29, 2026
Jan 20 2026
Newsfilter
FibroBiologics (FBLG) Stock Rises 7.68%, Attracts Market Attention
Jan 13 2026
NASDAQ.COM
FibroBiologics Files IND for CYPS317 Clinical Trials Targeting Psoriasis
Dec 31 2025
Globenewswire
FibroBiologics Files IND for CYPS317 Clinical Trials Targeting Psoriasis
Dec 31 2025
Newsfilter
FibroBiologics Closes $1.7 Million Registered Direct Offering
Dec 16 2025
Globenewswire
FibroBiologics Closes $1.7 Million Registered Direct Offering
Dec 16 2025
Newsfilter
FibroBiologics Issues 5.2M Shares at $0.33 Each in Direct Offering
Dec 15 2025
Globenewswire
FibroBiologics reveals $1.7M registered direct placement
Dec 15 2025
SeekingAlpha
FibroBiologics Submits New Patent for Fibroblast Technology to Expand Further into Orthopedic Field
Dec 10 2025
Benzinga
FibroBiologics Pays Off $15M Convertible Debt, Focuses on Clinical Trials
Nov 26 2025
Newsfilter
VTI ETF Daily Report—November 25, 2025
Nov 25 2025
TipRanks
FibroBiologics Issues 4.48M Shares at $0.335 Each in Direct Offering
Nov 24 2025
Newsfilter
VTI ETF Daily Report — November 21, 2025
Nov 21 2025
TipRanks
VTI ETF Daily Update - November 20, 2025
Nov 20 2025
TipRanks
Show More News
